# Exemestane

## Aromasin 25mg

| TAH Drug Code      | [OARO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OARO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjuvant treatment of postmenopausal women with oestrogen receptor +ve invasive early breast cancer, following at least 2 year of initial adjuvant tamoxifen therapy. Treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.                                                                                                                                                                                                                                                            |
| Dosing             | 25 mg administered orally once daily after a meal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Pregnancy, lactation. Women with premenopausal endocrine status.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Anorexia, insomnia, depression, headache, dizziness, carpal tunnel syndrome, hot flushes, nausea, abdominal pain, vomiting, constipation, dyspepsia, diarrhea, increased sweating, rash, alopecia, joint & musculoskeletal pain, fatigue, pain, peripheral oedema. Rarely, hepatitis including cholestatic hepatitis. Endocrine metabolic: Diaphoresis (6% to 17.8% ), Hot sweats (13% to 32.9% ) Gastrointestinal: Nausea (8.5% to 18% ) Musculoskeletal: Arthralgia (14.6% to 28.8% ) Neurologic: Headache (6.9% to 13.1% ), Insomnia (11% to 13.7% ) Psychiatric: Fatigue (11% to 22% ) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/exemestane-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

